Overweight with staged execution — wait for $180–181 first tranche instead of initiating at $186.93
Overweight rating maintained but staged execution required: do not initiate at current $186.93; wait for plan-defined $180–181 first tranche entry zone, then add on pullbacks to $175, with final tranche conditional on $202 reclaim or Q3 FY26 earnings catalyst. Hard stop at $170; sell half if weekly close breaks $160. Total cap 2–2.5% NAV.
| Position | Action |
|---|---|
| Total ACN position | Cap at 2–2.5% NAV; do not add if already above threshold |
| Hard stop | Sell all if weekly close below $160 |
| Tranche 1 (30% of intended position) | Enter at $180–181 with constructive price action |
| Tranche 2 (40% of intended position) | Add near $175 if volume stabilizes (not expanding on dip) |
| Tranche 3 (30% of intended position) | Enter on weekly close above $202 OR Q3 FY26 earnings confirmation (mid-single-digit revenue, bookings ≥ revenue, 16.5–17% margin, sustained FCF conversion) |
Accenture is a high-quality compounder in recovery mode, not a broken business—trading at a cyclical-trough forward P/E of 12.76x against 24.4% ROE and re-accelerating AI-driven demand, with capital return of ~$9.7B annually providing a mechanical floor under the equity.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $180.75 | bullish |
| 50 SMA | $153.54 | bullish |
| 200 SMA | $202.01 | bearish |
| MACD Line | 8.27 | bullish |
| MACD Signal | 7.82 | bullish |
| MACD Histogram | +0.44 | bullish |
| RSI | 68.17 | neutral |
| Bollinger Upper Band | $189.89 | neutral |
| Bollinger Middle Band | $175.79 | bullish |
| Bollinger Lower Band | $161.70 | bullish |
| ATR | 7.63 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price near $175 with stabilizing (non-expanding) volume on dip
Then: Deploy 40% of intended position
AI services demand is delivering realized results, not speculative promise
↩ rebuts: “Bear's AI disruption thesis”
EV: ~44% over 3 years (Trefis moderate recovery scenario from $185.28) · concedes: Options are pricing a wide outcome range — true, and that uncertainty is about timing of re-rating, not direction; Bearish divergence could form near $190 — agreed, tactical entry is on pullbacks to $175-181; High implied volatility means put protection is relatively expensive; Do not chase the upper Bollinger Band at current levels; The 200 SMA at $202 is real overhead resistance to be respected
Accenture is a mature, decelerating business facing structural growth headwinds from AI commoditization, hidden balance sheet risk in $25B of goodwill, a technically extended chart after a 27% one-month rally, and a macro regime that does not support multiple expansion — fade the rally toward $190.
EV: $165-175 (bear case target)
→ vs conservative: Waiting for $180-181 is leaving serious money on the table; the stock may not revisit that level in a momentum regime change and waiting means missing the entire move
→ vs conservative: Capping exposure at 2-2.5% of NAV treats ACN like a speculative biotech rather than a market-leading tech services franchise with 24% ROE and best-in-class fundamentals
→ vs neutral: MACD histogram compression during a strong uptrend is not a reversal signal, it's evidence that momentum is becoming more sustainable rather than parabolic
→ vs neutral: RSI at 68 after a 27% monthly rally is evidence of strength not exhaustion; RSI was at 25 in late June and the stock is in a regime change from oversold recovery to sustainable uptrend
| neutral |
| VWMA | $178.56 | bullish |
| Close | $186.93 | neutral |
Support: 180.75 · 175.79 · 161.7 | Resistance: 189.89 · 202.01
ACN shows a textbook early-stage recovery posture: short-term bullish momentum (price > 10 EMA > 50 SMA) with MACD positive but histogram decelerating, and RSI approaching overbought at 68.17. The Bollinger upper band at $189.89 is the immediate technical ceiling, while the 200 SMA at $202.01 represents major long-term resistance. Volatility is normalizing (ATR 7.63, down from ~8.5), and VWMA at $178.56 confirms the rally has genuine volume support. The recommendation is a balanced HOLD: existing longs with tight stops ($15 buffer/2×ATR), new entries on pullbacks to $175–181, and aggressive addition only on sustained close above $190.
Market Cap
$114.4B
P/E (TTM)
14.93
Forward P/E
12.76
PEG Ratio
1.35
P/B
3.59
Dividend Yield
3.5%
Beta
1.07
52W High
$291.09
52W Low
$118.15
50-Day MA
$153.73
200-Day MA
$205.46
Revenue (TTM)
$73.10B
Gross Profit (TTM)
$23.40B
Gross Margin
32.0%
EBITDA (TTM)
$12.94B
EBITDA Margin
17.7%
Operating Income (TTM)
$12.4B (16.96% margin)
Net Income (TTM)
$7.79B
Net Margin
10.66%
Diluted EPS (TTM)
$12.52
Forward EPS
$14.65
Operating Margin
16.96%
Return on Equity (ROE)
24.41%
Return on Assets (ROA)
10.90%
Book Value per Share
$52.12
Total Assets
$68.81B
Total Equity
$31.89B
Working Capital
$7.33B
Total Debt
$8.39B
Cash & Equivalents
$10.17B
Goodwill
$25.32B
Net Tangible Assets
$4.07B
Current Ratio
1.34
Capital Lease Obligations
$3.25B
Debt-to-Equity (True)
0.26x
Free Cash Flow (TTM)
$12.09B
CapEx (TTM est.)
~$0.6B
FCF Conversion
~155% of net income
Dividends Paid (TTM est.)
~$4.0B
Buybacks (TTM est.)
~$5.7B
Total Shareholder Return (TTM)
~$9.7B (~8.5% of market cap)
Diluted Shares (Q2 FY26)
615.6M
Treasury Shares
55.6M
Stock-Based Compensation
~$462M/quarter (~$1.85B annualized)
Strengths
Concerns
Accenture (NYSE: ACN) presents a compelling high-quality investment at forward P/E of 12.76x with exceptional fundamentals including 24.41% ROE, $12.09B TTM free cash flow, and 16.96% operating margins. The stock has experienced significant multiple compression (down ~47% from $291.09 high) but underlying business quality remains robust with revenue re-accelerating to +5.6% YoY and aggressive capital return programs returning ~$9.7B annually to shareholders. A HOLD/ACCUMULATE stance is recommended pending Q3 FY26 earnings for confirmation of AI-services demand traction, with staged buying recommended given technical damage and sector cyclicality risks.